These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23008819)

  • 21. Nanostructured Lipid Carrier-loaded In situ Gel for Ophthalmic Drug Delivery: Preparation and In vitro Characterization Studies.
    Sabale V; Belokar V; Jiwankar M; Sabale P
    Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38213174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
    Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
    Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole.
    Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R
    Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Characterization of Undecylenoyl Phenylalanine Loaded-Nanostructure Lipid Carriers (NLCs) as a New α-MSH Antagonist and Antityrosinase Agent.
    Vaziri MS; Tayarani-Najaran Z; Kabiri H; Nasirizadeh S; Golmohammadzadeh S; Kamali H
    Adv Pharm Bull; 2023 Mar; 13(2):290-300. PubMed ID: 37342381
    [No Abstract]   [Full Text] [Related]  

  • 28. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 30. Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study.
    Ahmed S; Mahmood S; Danish Ansari M; Gull A; Sharma N; Sultana Y
    Int J Pharm; 2021 Sep; 607():121006. PubMed ID: 34391848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
    Liu K; Sun J; Wang Y; He Y; Gao K; He Z
    Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
    Nagaich U; Gulati N
    Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
    Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
    Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.
    Bhatt S; Sharma JB; Kamboj R; Kumar M; Saini V; Mandge S
    Turk J Pharm Sci; 2021 Feb; 18(1):61-67. PubMed ID: 33633486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
    Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
    J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical phenytoin nanostructured lipid carriers: design and development.
    Motawea A; Borg T; Abd El-Gawad AEH
    Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis.
    Youssef A; Dudhipala N; Majumdar S
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32575524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.